Cilostazol Tablet
Product Images NDC 42291-453

4 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 42291-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60 (453 60)

60 (453 60)
Packaging label for Cilostazol Tablets USP 100 mg by AvKARE. The label states 60 tablets per package, with dispensing instructions for pharmacists and storage conditions. It includes the product NDC 42291-453-60 and a barcode.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A plasma concentration versus time graph showing the levels of cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol over 24 hours. The graph includes three curves indicating the concentration changes of each compound following oral administration.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A bar chart comparing percent mean improvement in maximal walking distance among three groups: placebo, cilostazol 50 mg twice daily, and cilostazol 100 mg twice daily across eight clinical trials with varying durations ranging from 12 to 24 weeks. The chart shows relative increases in walking distance over placebo for the two cilostazol dosages in each trial.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of cilostazol showing its molecular components and bonds in a standard line structure format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.